<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320844">
  <stage>Registered</stage>
  <submitdate>18/11/2009</submitdate>
  <approvaldate>20/11/2009</approvaldate>
  <actrnumber>ACTRN12609001006235</actrnumber>
  <trial_identification>
    <studytitle>Central Australia Swab Study: an assessment of circulating respiratory pathogens in a remote Indigenous community</studytitle>
    <scientifictitle>A pilot study to assess the presence of circulating respiratory pathogens in a remote Indigenous community using different specimen transport methods and sensitive molecular techniques</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Viral respiratory infections</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Studies of infection and infectious agents</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Epidemiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Nasal swabs from people with and without respiratory symptoms presenting to the community clinic over a 3 week period that are sent to the laboratory by routine mail. Two anterior nasal swabs are collected from each participant. The L nare specimen is sent by mail and the R nare specimen is transported frozen.</interventions>
    <comparator>Nasal swabs from people with and without respiratory symptoms presenting to the community clinic over a 3 week period that are sent to the laboratory frozen. Two anterior nasal swabs are collected from each participant. The L nare specimen is sent by mail and the R nare specimen is transported frozen.</comparator>
    <control>Active</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The proportion of nasal swabs that are positive for influenza virus by real-time polymerase chain reaction(PCR) in those that are sent by post compared to those that sent by frozen</outcome>
      <timepoint>Single study visit</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The prevalence of circulating respiratory viruses  present in the nasopharynx in are remote Indigenous community. Viruses to be tested for include:
1. adenovirus
2. Respiratory Syncytial Virus (RSV), 
3. influenza, 
4. Parainfluenza Virus (PIV) types 1,2,3
5. Human Metapneumovirus (hMPV), 
6. Rhinoviruses (RVs), 
7. Human Coronaviruses (hCOV), 
8. Bocavirus 
9. Karolinska Institute Virus (KI) 
10. Washington University Virus (WU)</outcome>
      <timepoint>Single study visit</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Resident in a remote Indigenous community in the 14 days prior to the study visit.

2. Provision of written informed consent</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Days</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>12/08/2009</anticipatedstartdate>
    <actualstartdate>12/08/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>31/08/2009</actualenddate>
    <samplesize>140</samplesize>
    <actualsamplesize>140</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>31/08/2009</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Menzies School of Health Research</primarysponsorname>
    <primarysponsoraddress>PO Box 41096 
Casuarina NT 0811</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Menzies School of Health Research</fundingname>
      <fundingaddress>PO Box 41096 
Casuarina NT 0811</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Centre for Clinical Research Excellence in Child and Adolescent Immunisation</fundingname>
      <fundingaddress>School of Population Health
University of Melbourne, VIC, 3010</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>GlaxoSmithKline Australia - Biologicals</fundingname>
      <fundingaddress>1061 Mountain Hwy (PO Box 168)
Boronia VIC 3155, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Centre for Clinical Research Excellence in Child &amp; Adolescent Immunisation</sponsorname>
      <sponsoraddress>School of Population Health
University of Melbourne, VIC, 3010</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is determine the best method for transporting respiratory specimens for viral studies from remote Indigenous communities. The study will enable planning for respiratory illness surveillance and interventions in remote areas. 

The primary hypothesis is that there is no difference in the proportion of respiratory viruses detected in nasal swabs collected from children and adults in the community that have been frozen immediately compared to specimens that have been sent via routine post.</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>1. O'Grady KF, Torzillo PJ, Rockett R, Whiley DM, Sloots T, Nissen MD, Lambert SB. Successful application of a simple transport method for the conduct of respiratory virus surveillance in remote Indigenous communities in Australia. Trop Med Int Health. 2011. 16(6): 766-772

2. OGrady KF, Whiley DM, Torzillo PJ, Sloots TP, Lambert SB. Mailed versus frozen transport of nasal specimens for bacterial PCR. BMC Infectious Diseases. 2013 Nov 14;13:543

</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Central AustraliaHuman Research Ethics Committee</ethicname>
      <ethicaddress>Centre for Remote Health
PO Box 4066
Alice Springs NT 0871</ethicaddress>
      <ethicapprovaldate>4/08/2009</ethicapprovaldate>
      <hrec>4/02/2009</hrec>
      <ethicsubmitdate>9/02/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kerry-Ann O'Grady</name>
      <address>Menzies School of Health Research
PO Box 41096
Casuarina, NT, 0811</address>
      <phone>+61 8 8922 6969</phone>
      <fax />
      <email>kogrady@menzies.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kerry-Ann O'Grady</name>
      <address>Menzies School of Health Research
PO Box 41096
Casuarina, NT, 0811</address>
      <phone>+61 8 8922 6969</phone>
      <fax />
      <email>kogrady@menzies.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kerry-Ann O'Grady</name>
      <address>Menzies School of Health Research
PO Box 41096
Casuarina, NT, 0811</address>
      <phone>+61 8 8922 6969</phone>
      <fax />
      <email>kogrady@menzies.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>